Evidence map›Paper›PMID 35803258›Full record

ArticlePlanta medica2022

Exploring the Immunotherapeutic Potential of Oleocanthal against Murine Cutaneous Leishmaniasis.

Kalliopi Karampetsou, Olga S Koutsoni, Fotis Badounas, Apostolis Angelis, Georgia Gogou, Leandros-Alexios Skaltsounis, Maria Halabalaki, Eleni Dotsika

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Planta medica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kalliopi KarampetsouLaboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Olga S KoutsoniLaboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Fotis BadounasMolecular Genetics Laboratory, Department of Immunology, Transgenic Technology Laboratory, Hellenic Pasteur Institute, Athens, Greece.
Apostolis AngelisDivision of Pharmacognosy and Natural Product Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Georgia GogouLaboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Leandros-Alexios SkaltsounisDivision of Pharmacognosy and Natural Product Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Maria HalabalakiDivision of Pharmacognosy and Natural Product Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Eleni DotsikaLaboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Pasteur Hellenic Institute · GRNational and Kapodistrian University of Athens · GR

Funding

GA. no.Ψ3Β246ΨΖ2Ν-Σ3Γ Hellenic Foundation for Research and Innovation (HFRI)MIS5002486 Operational Strategic Reference Framework (NSFR 2014-2020)MIS5028091 Operational Strategic Reference Framework (NSFR 2014-2020)
6 · The paper itself

Abstract

Leishmaniasis is a major tropical disease with increasing global incidence. Due to limited therapeutic options with severe drawbacks, the discovery of alternative treatments based on natural bioactive compounds is important. In our previous studies we have pointed out the antileishmanial activities of olive tree-derived molecules. In this study, we aimed to investigate the

Indexed as

Antiprotozoal AgentsLeishmaniasisLeishmaniasis, CutaneousAldehydesAnimalsCyclopentane MonoterpenesImmunotherapyMiceMice, Inbred BALB CPhenolsAldehydesAntiprotozoal AgentsCyclopentane MonoterpenesoleocanthalPhenols

Identifiers

PMID35803258
PMCPMC9343937
OpenAlexW4284962338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.